Ms Juliet Hounsome

2026

• Channon, S. et al. 2026. P340 - ECE_1053 - Research priorities for polycystic ovary syndrome: results of a priority setting partnership [Abstract]. European journal of endocrinology 195 (S1) 484. (10.1093/ejendo/lvag096.484)
• Edwards, D. et al. 2026. Unified tools for assessing the methodological quality of intervention effects in rapid reviews: a scoping review. Systematic Reviews (10.1186/s13643-026-03270-2)
• Kiseleva, M. et al. 2026. A rapid review of multi-agency working to support transition out of children’s social care. (10.31235/osf.io/78zeu_v1)
• Channon, S. et al. 2026. Research priorities for polycystic ovary syndrome. The Lancet Obstetrics, Gynaecology, & Women’s Health 2 (4), pp.e272-e274. (10.1016/s3050-5038(26)00018-x)
• Csontos, J. et al. 2026. Interventions that support women, girls, and people who menstruate to participate in physical activity: a rapid overview of reviews. BMC Public Health 26 1472. (10.1186/s12889-026-27122-9)
• Edwards, D. et al. 2026. Unified tools for assessing the methodological quality of intervention effects in rapid reviews: a scoping review. Unified tools for assessing the methodological quality of intervention effects in rapid reviews: a scoping review (10.21203/rs.3.rs-8724550/v3)
• England, C. et al. 2026. Complications and costs to the UK National Health Service due to outward medical tourism for elective surgery: a rapid review. BMJ Open 16 (1) e109050. (10.1136/bmjopen-2025-109050)

2025

• Edwards, D. et al. 2025. Safe staffing in maternity services: A commissioned rapid scoping review for NHS England. Technical Report.
• Kiseleva, M. et al. 2025. Learning Disability Liaison services in acute care: a rapid review of effectiveness, barriers, and facilitators [Preprint]. null (10.31234/osf.io/j5pqh_v1)
• Kiseleva, M. et al. 2025. A rapid review of interventions to reduce suicide ideation, attempts, and deaths at public locations. null (10.1101/2025.04.09.25325515)

2024

• Kiseleva, M. et al. 2024. Rapid review of the characteristics and outcomes of children involved in private family law proceedings due to parental separation. [Online].MedRXiv. (10.1101/2024.12.04.24318480)Available at: https://doi.org/10.1101/2024.12.04.24318480.
• Csontos, J. et al. 2024. The effectiveness of interventions that support women, girls, and people who menstruate to participate in physical activity: a rapid overview of reviews. Research Square (https://doi.org/10.21203/rs.3.rs-5098557/v1)
• Csontos, J. et al. 2024. Supporting women, girls and people who menstruate to participate in physical activity – Rapid evidence summary. [Online].medRxiv. (https://doi.org/10.1101/2024.09.02.24311982)Available at: https://doi.org/10.1101/2024.09.02.24311982.
• Edwards, D. et al. 2024. A rapid review of the effectiveness of interventions to enhance equitable or overall access to mental health services by ethnic minority groups. [Online].medRxiv. (https://doi.org/10.1101/2024.05.16.24307468)Available at: https://doi.org/10.1101/2024.05.16.24307468.
• Csontos, J. et al. 2024. What works to support better access to mental health services (from primary care to inpatients) for minority groups to reduce inequalities? A rapid evidence summary. [Online].medRxiv. (https://doi.org/10.1101/2024.02.28.24303432)Available at: https://doi.org/10.1101/2024.02.28.24303432.

2022

• Boyland, E. et al., 2022. Systematic review of the effect of policies to restrict the marketing of foods and non-alcoholic beverages to which children are exposed. Obesity Reviews 23 (8) e13447. (10.1111/obr.13447)
• Boyland, E. et al., 2022. Association of food and nonalcoholic beverage marketing with children and adolescents' eating behaviors and health A systematic review and meta-analysis. JAMA Pediatrics 176 (7) e221037. (10.1001/jamapediatrics.2022.1037)

2020

• Hounsome, J. et al. 2020. Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation. Health Technology Assessment 24 (30)(10.3310/hta24300)
• Fleeman, N. et al., 2020. Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. Health Technology Assessment 24 (2), pp.1-180. (10.3310/hta24020)

2019

• Bresnahan, R. et al., 2019. Topiramate add-on therapy for drug-resistant focal epilepsy.. The Cochrane Database of Systematic Reviews (10) CD001417. (10.1002/14651858.CD001417.pub4)

2018

• Aslam, R. et al. 2018. A systematic review of the diagnostic accuracy of automated tests for cognitive impairment. International Journal of Geriatric Psychiatry 33 (4), pp.561-575. (10.1002/gps.4852)
• Hounsome, J. et al. 2018. The structured assessment of violence risk in adults with intellectual disability: a systematic review.. Journal of Applied Research in Intellectual Disabilities 31 (1), pp.e1-e17. (10.1111/jar.12295)

2017

• Hounsome, J. et al. 2017. A systematic review of information format and timing before scheduled adult surgery for peri-operative anxiety. Anaesthesia: Peri-operative medicine, critical care and pain 72 (10), pp.1265-1272. (10.1111/anae.14018)
• Hounsome, J. et al. 2017. Nitrous oxide-based vs. nitrous oxide-free general anaesthesia and accidental awareness in surgical patients: an abridged Cochrane systematic review.. Anaesthesia: Peri-operative medicine, critical care and pain 73 (3), pp.365-374. (10.1111/anae.14065)
• Feinberg, J. et al., 2017. Drug-eluting stents versus bare-metal stents for acute coronary syndrome. Cochrane Library (8) CD012481. (10.1002/14651858.CD012481.pub2)

2016

• Nielsen, E. E. et al., 2016. Drug-eluting stents versus bare-metal stents for stable ischaemic heart disease. Cochrane Library (12) CD012480. (10.1002/14651858.CD012480)
• Weston, J. et al., 2016. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database of Systematic Reviews (11) CD010224. (10.1002/14651858.CD010224.pub2)
• Aslam, R. W. et al., 2016. Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review. Health Technology Assessment 20 (77)(10.3310/hta20770)
• Hounsome, J. et al. 2016. Nitrous oxide-based versus nitrous oxide-free general anaesthesia and accidental awareness during general anaesthesia in surgical patients. Cochrane Database of Systematic Reviews (8) CD011052. (10.1002/14651858.CD011052.pub2)

2015

• Nicholson, A. et al., 2015. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation. Health Technology Assessment 19 (87)(10.3310/hta19870)
• Greenhalgh, J. et al., 2015. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation. Health Technology Assessment 19 (47)(10.3310/hta19470)
• Greenhalgh, J. et al., 2015. Eribulin for the treatment of advanced or metastatic breast cancer: A NICE single technology appraisal. PharmacoEconomics 33 (2), pp.137-148. (10.1007/s40273-014-0214-2)

2013

• Boyle, R. J. et al., 2013. Immunotherapy for Hymenoptera venom allergy: too expensive for European health care?. Allergy 68 (10), pp.1341-1342. (10.1111/all.12210)
• Whittington, R. et al., 2013. A systematic review of risk assessment strategies for populations at high risk of engaging in violent behaviour: update 2002-8. Health Technology Assessment 17 (50)(10.3310/hta17500)
• Dickson, R. et al., 2013. Erlotinib in monoterapia nel trattamento di mantenimento del carcinoma polmonare non a piccole cellule dopo chemioterapia a base di platino. PharmacoEconomics Italian Research Articles 15 (1), pp.35-44. (10.1007/s40276-013-0004-4)
• Greenhalgh, J. et al., 2013. Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin?s Lymphoma. PharmacoEconomics 31 (5), pp.403. (10.1007/s40273-013-0043-8)

2012

• Boyle, R. J. et al., 2012. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database of Systematic Reviews 2015 (2)(10.1002/14651858.CD008838.pub2)
• Hockenhull, J. et al. 2012. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy. Health Technology Assessment 16 (12)(10.3310/hta16120)

2011

• Dickson, R. et al., 2011. Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy. PharmacoEconomics 29 (12), pp.1051-1062. (10.2165/11591600-000000000-00000)

2010

• Palmer, E. J. et al., 2010. Offending behaviour programmes in the community: The effects on reconviction of three programmes with adult male offenders. Legal and Criminological Psychology 12 (2), pp.261-264. (10.1348/135532506X138873)
• Brown, T. et al., 2010. Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. Health Technology Assessment 14 (Suppl) 10. (10.3310/hta14Suppl2-10)
• Martin Saborido, C. et al., 2010. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy. Health Technology Assessment 14 (31)(10.3310/hta14310)
• Greenhalgh, J. et al., 2010. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database of Systematic Reviews 12 (5)(10.1002/14651858.CD004587.pub2)

2009

• Bagust, A. et al., 2009. Rituximab for the treatment of rheumatoid arthritis. Health Technology Assessment 13 (Suppl) 4. (10.3310/hta13Suppl2-04)
• Boland, A. et al., 2009. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma. Health Technology Assessment 13 (Suppl) 6. (10.3310/hta13Suppl2-06)
• Dundar, Y. et al., 2009. Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma. Health Technology Assessment 13 (Suppl) 4. (10.3310/hta13Suppl1-04)
• Palmer, E. J. et al., 2009. Allocation to offending behavior programs in the english and welsh probation service. Criminal Justice and Behavior 36 (9), pp.909-922. (10.1177/0093854809338889)
• McLeod, C. et al., 2009. Erlotinib for the treatment of relapsed non-small cell lung cancer. Health Technology Assessment 13 (Suppl), pp.41-47. 7. (10.3310/hta13suppl1-07)
• Hounsome, J. C. et al. 2009. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review*. Critical Care Medicine 37 (2), pp.702-712. (10.1097/ccm.0b013e3181958915)

2008

• Hatcher, R. M. et al., 2008. Aggression replacement training with adult male offenders within community settings: a reconviction analysis. Journal of Forensic Psychiatry & Psychology 19 (4), pp.517-532. (10.1080/14789940801936407)
• Palmer, E. J. et al., 2008. The importance of appropriate allocation to offending behavior programs. International Journal of Offender Therapy and Comparative Criminology 52 (2), pp.206-221. (10.1177/0306624X07303877)
• Hounsome, J. et al. 2008. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technology Assessment 12 (12), pp.1-154. (10.3310/hta12120)
• Hollin, C. R. et al., 2008. Cognitive skills behavior programs for offenders in the community. Criminal Justice and Behavior 35 (3), pp.269-283. (10.1177/0093854807312234)

2007

• McGuire, J. et al., 2007. Evaluation of structured cognitive-behavioural treatment programmes in reducing criminal recidivism. Journal of Experimental Criminology 4 (1), pp.21-40. (10.1007/s11292-007-9047-8)